Canaan VII

Canaan VII is an early-stage venture capital fund managed by Canaan Partners, a firm founded in 1987 and based in San Francisco, California. Canaan Partners specializes in investing in innovative entrepreneurs, focusing primarily on the technology and healthcare sectors. The fund emphasizes investments in software and technology, media, and telecommunications. Over its 30 years of operation, Canaan has successfully managed over $5 billion in assets and completed more than 190 exits, demonstrating a strong track record in nurturing and scaling companies. With a team experienced in technology, infrastructure, communications, and life sciences, Canaan is committed to supporting promising ventures across a range of industries, ensuring it targets high-potential opportunities in the United States.

Brent Ahrens

General Partner

Brenton K. Ahrens

General Partner - West Coast

Nandu Anilal

Vice President

John Balen

Partner - West Coast

Stephen Bloch

General Partner - East Coast

Richard Boyle

General Partner - West Coast

Laura Chau

Partner

Brendan Dickinson

General Partner

Rayfe Gaspar-Asaoka

Partner

Julie Papanek Grant

General Partner

Stephen Green

Venture Partner

Wende Hutton

General Partner

Maha Ibrahim

General Partner - West Coast

Deepak Kamra

General Partner - West Coast

Nina Kjellson

General Partner - West Coast

Mark Mangiola

Venture Partner

Jared Newman

Vice President

Julie Papanek

Partner

Guy Russo

General Partner - East Coast

Timothy Shannon

General Partner

Hrach Simonian

General Partner - West Coast

Dana Warren

Venture Partner, East Coast

Bob Williams

Venture Partner - West Coast

Eric Young

Partner and Co-Founder

Past deals in DRM

Dragos

Series D in 2021
Dragos is a cybersecurity company focused on safeguarding critical infrastructure within the industrial sector. Headquartered in the Washington, DC area, with additional offices in Houston and Australia, Dragos provides an integrated software platform that enhances visibility into industrial control systems (ICS) and operational technology (OT) networks. This platform enables organizations to identify and mitigate threats before they escalate into significant incidents. Dragos serves a diverse range of industries, including power and water utilities, energy, and manufacturing, and its solutions are specifically designed to address the challenges posed by emerging applications like the Industrial Internet of Things (IIoT). By codifying the expertise of its cybersecurity professionals, Dragos aims to establish a resilient security posture for its clients, ultimately contributing to the protection of civilization.

Dragos

Series C in 2020
Dragos is a cybersecurity company focused on safeguarding critical infrastructure within the industrial sector. Headquartered in the Washington, DC area, with additional offices in Houston and Australia, Dragos provides an integrated software platform that enhances visibility into industrial control systems (ICS) and operational technology (OT) networks. This platform enables organizations to identify and mitigate threats before they escalate into significant incidents. Dragos serves a diverse range of industries, including power and water utilities, energy, and manufacturing, and its solutions are specifically designed to address the challenges posed by emerging applications like the Industrial Internet of Things (IIoT). By codifying the expertise of its cybersecurity professionals, Dragos aims to establish a resilient security posture for its clients, ultimately contributing to the protection of civilization.

Dragos

Series B in 2018
Dragos is a cybersecurity company focused on safeguarding critical infrastructure within the industrial sector. Headquartered in the Washington, DC area, with additional offices in Houston and Australia, Dragos provides an integrated software platform that enhances visibility into industrial control systems (ICS) and operational technology (OT) networks. This platform enables organizations to identify and mitigate threats before they escalate into significant incidents. Dragos serves a diverse range of industries, including power and water utilities, energy, and manufacturing, and its solutions are specifically designed to address the challenges posed by emerging applications like the Industrial Internet of Things (IIoT). By codifying the expertise of its cybersecurity professionals, Dragos aims to establish a resilient security posture for its clients, ultimately contributing to the protection of civilization.

Dermira

Series C in 2014
Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients. Dermira’s portfolio of five product candidates targets significant market opportunities. It was founded in 2010 and headquartered in Menlo Park, California.

Dermira

Series B in 2013
Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients. Dermira’s portfolio of five product candidates targets significant market opportunities. It was founded in 2010 and headquartered in Menlo Park, California.

Dermira

Series A in 2011
Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients. Dermira’s portfolio of five product candidates targets significant market opportunities. It was founded in 2010 and headquartered in Menlo Park, California.

Chimerix

Series F in 2011
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, dedicated to developing innovative antiviral therapeutics for patients with serious diseases, including cancer and those undergoing transplant procedures. The company’s lead candidate, CMX001, targets life-threatening double-stranded DNA viral infections and has demonstrated antiviral activity in clinical studies involving immunocompromised patients. Ongoing research includes a Phase 2 study for preventing cytomegalovirus in stem cell transplant recipients and other studies addressing adenovirus and various herpes viruses. Chimerix is also developing CMX157, a nucleoside analogue aimed at treating HIV and hepatitis B, which has shown promising results in early trials. Additionally, the company is working on dociparstat sodium, a compound intended to inhibit key proteins linked to acute myeloid leukemia, and brincidofovir, an antiviral candidate for smallpox. Chimerix holds various licensing agreements to advance its research and has received substantial federal funding to support its initiatives in public health and medical countermeasures.

Chimerix

Series E in 2009
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, dedicated to developing innovative antiviral therapeutics for patients with serious diseases, including cancer and those undergoing transplant procedures. The company’s lead candidate, CMX001, targets life-threatening double-stranded DNA viral infections and has demonstrated antiviral activity in clinical studies involving immunocompromised patients. Ongoing research includes a Phase 2 study for preventing cytomegalovirus in stem cell transplant recipients and other studies addressing adenovirus and various herpes viruses. Chimerix is also developing CMX157, a nucleoside analogue aimed at treating HIV and hepatitis B, which has shown promising results in early trials. Additionally, the company is working on dociparstat sodium, a compound intended to inhibit key proteins linked to acute myeloid leukemia, and brincidofovir, an antiviral candidate for smallpox. Chimerix holds various licensing agreements to advance its research and has received substantial federal funding to support its initiatives in public health and medical countermeasures.

Chimerix

Series D in 2007
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, dedicated to developing innovative antiviral therapeutics for patients with serious diseases, including cancer and those undergoing transplant procedures. The company’s lead candidate, CMX001, targets life-threatening double-stranded DNA viral infections and has demonstrated antiviral activity in clinical studies involving immunocompromised patients. Ongoing research includes a Phase 2 study for preventing cytomegalovirus in stem cell transplant recipients and other studies addressing adenovirus and various herpes viruses. Chimerix is also developing CMX157, a nucleoside analogue aimed at treating HIV and hepatitis B, which has shown promising results in early trials. Additionally, the company is working on dociparstat sodium, a compound intended to inhibit key proteins linked to acute myeloid leukemia, and brincidofovir, an antiviral candidate for smallpox. Chimerix holds various licensing agreements to advance its research and has received substantial federal funding to support its initiatives in public health and medical countermeasures.

Everdream

Series F in 2005
Everdream Corporation specializes in providing on-demand personal computer and desktop management software services on an international scale. The company offers a comprehensive suite of compliance software that enables visibility into hardware and software assets, tracks software license usage, and automates software distribution to ensure regulatory compliance. Additionally, Everdream provides an uptime software services suite that safeguards against internet attacks, hackers, and data loss through malware protection, patch management, and online data backup. The company also delivers IT support services, including on-demand employee service desk solutions and remote control services, alongside managed services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc. since December 2007.

Everdream

Series D in 2003
Everdream Corporation specializes in providing on-demand personal computer and desktop management software services on an international scale. The company offers a comprehensive suite of compliance software that enables visibility into hardware and software assets, tracks software license usage, and automates software distribution to ensure regulatory compliance. Additionally, Everdream provides an uptime software services suite that safeguards against internet attacks, hackers, and data loss through malware protection, patch management, and online data backup. The company also delivers IT support services, including on-demand employee service desk solutions and remote control services, alongside managed services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc. since December 2007.

Everdream

Series C in 2000
Everdream Corporation specializes in providing on-demand personal computer and desktop management software services on an international scale. The company offers a comprehensive suite of compliance software that enables visibility into hardware and software assets, tracks software license usage, and automates software distribution to ensure regulatory compliance. Additionally, Everdream provides an uptime software services suite that safeguards against internet attacks, hackers, and data loss through malware protection, patch management, and online data backup. The company also delivers IT support services, including on-demand employee service desk solutions and remote control services, alongside managed services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc. since December 2007.

Everdream

Series B in 2000
Everdream Corporation specializes in providing on-demand personal computer and desktop management software services on an international scale. The company offers a comprehensive suite of compliance software that enables visibility into hardware and software assets, tracks software license usage, and automates software distribution to ensure regulatory compliance. Additionally, Everdream provides an uptime software services suite that safeguards against internet attacks, hackers, and data loss through malware protection, patch management, and online data backup. The company also delivers IT support services, including on-demand employee service desk solutions and remote control services, alongside managed services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc. since December 2007.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.